These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38942386)
1. Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III Study. Wolf S; Stanga PE; Veselovsky M; Veith M; Papp A; Mange S; Kanta Mondal L; Romanczak D; Janco L; Chauhan R; Romanowska-Dixon B; Eremina A; Zavgorodnya N; Dusova J; Sagong M; Kim S; Ahn K; Kim S; Bae Y; Lee S; Kang H; Brown DM Ophthalmol Retina; 2024 Dec; 8(12):1163-1173. PubMed ID: 38942386 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration. Karkhaneh R; Faghihi H; Riazi-Esfahani H; Abrishami M; Bazvand F; Ebrahimiadib N; Johari M; Akhlaghi M; Shoeibi N; Nowroozzadeh MH; Ansari Astaneh MR; Khojasteh H; Imani Fooladi M; Khodabande A; Ghassemi F; Khalili Pour E; Zarei M; Mirshahi A; Fazel F; Ashraf H; Hosseini SM; Dourandeesh M; Feghhi M; Alizadeh Y; Behboudi H; Azadi P; Sabzvari A; Kafi H; Ghasemi Falavarjani K Ophthalmol Retina; 2024 Aug; 8(8):744-753. PubMed ID: 38428459 [TBL] [Abstract][Full Text] [Related]
3. The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema. Maguire M; Laidlaw D; Davies N; Hammond C Graefes Arch Clin Exp Ophthalmol; 2024 Nov; 262(11):3501-3508. PubMed ID: 38771336 [TBL] [Abstract][Full Text] [Related]
4. Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes. Agostini H; Abreu F; Baumal CR; Chang DS; G Csaky K; Demetriades AM; Kodjikian L; Lim JI; Margaron P; Monés JM; Peto T; Ricci F; Rüth M; Singh RP; Stoilov I; Swaminathan B; Willis JR; Westenskow PD Graefes Arch Clin Exp Ophthalmol; 2024 Nov; 262(11):3437-3451. PubMed ID: 38847896 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis. Nichani PAH; Popovic MM; Mihalache A; Pathak A; Muni RH; Wong DTW; Kertes PJ Ophthalmologica; 2024; 247(5-6):355-372. PubMed ID: 39362194 [TBL] [Abstract][Full Text] [Related]
6. Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial. Nielsen JS; Chang A; Holekamp NM; Cavichini-Cordeiro M; Lin SL; Heinrich D; Maass KF; Menezes A; Singh N; Pieramici DJ Ophthalmol Retina; 2024 Dec; 8(12):1127-1139. PubMed ID: 38914294 [TBL] [Abstract][Full Text] [Related]
7. Effects on corneal endothelium of intravitreal injection of anti-VEGF drugs. Malvasi M; Calandri A; Pacella E; Vingolo EM Cutan Ocul Toxicol; 2024 Dec; 43(4):369-382. PubMed ID: 39560148 [TBL] [Abstract][Full Text] [Related]
8. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
9. Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population. Fukuda Y; Notomi S; Shiose S; Maehara Y; Kiyohara K; Fujiwara K; Hashimoto S; Kano K; Ishikawa K; Hisatomi T; Sonoda KH Graefes Arch Clin Exp Ophthalmol; 2024 Dec; 262(12):3971-3978. PubMed ID: 39073562 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy: The ILUvien in Postoperative CYstoid Macular eDema Study. Motloch K; Soler V; Delyfer MN; Vasseur V; Wolff B; Issa M; Dot C; Massé H; Weber M; Comet A; Hitzl W; Matonti F; Creuzot-Garcher C; Tadayoni R; Kodjikian L; Couturier A Ophthalmol Retina; 2024 Dec; 8(12):1181-1191. PubMed ID: 39004282 [TBL] [Abstract][Full Text] [Related]
11. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology. Nakao S; Kusuhara S; Murakami T Graefes Arch Clin Exp Ophthalmol; 2024 Dec; 262(12):3749-3759. PubMed ID: 38995350 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
13. Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study. Chakraborty D; Sinha TK; Maiti A; Boral SK; Das A; Mondal S; Nandi K; Bhattacharya R Clin Ophthalmol; 2024; 18():3449-3456. PubMed ID: 39618985 [TBL] [Abstract][Full Text] [Related]